Intravenous antibiotics delivered at home
Intravenous Antibiotic Treatment at Home: A New Model for Across Services Interaction With the Use of Welfare Technology and Telemedicine.
This project will try a new model that uses telemedicine and welfare technology to let suitable patients receive intravenous antibiotics at home while the hospital and municipal services share information and care tasks.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Helse Møre og Romsdal HF Government |
| Locations | 1 site (Kristiansund) |
| Trial ID | NCT04898452 on ClinicalTrials.gov |
What this trial studies
This observational project develops and tests a cross‑service care model linking hospital and municipal providers using welfare technology and telemedicine to support home intravenous antibiotic therapy. Sub‑study 1 used a user‑centered qualitative approach with interviews, observations and group discussions involving patients, next of kin and health professionals to design and refine routines, information exchange and quality procedures. Sub‑study 2 is quantitative and will collect descriptive data from hospital and municipal records, alarm logs from the regional response center and infusion pump logs to evaluate feasibility, safety and workflow. Findings will be used to further develop the service and aim to make the model transferable to other diagnoses, treatment methods and geographic areas.
Who should consider this trial
Good fit: Ideal candidates are medically stable patients who need intravenous antibiotics that cannot be given orally, can give informed consent, can learn and manage pump handling and other procedures, and have a home environment suitable for IV therapy.
Not a fit: Patients who are clinically unstable, require frequent hands‑on observation, cannot manage pump procedures, lack a suitable home environment, or whose antibiotics are unsuitable for the selected pumps are unlikely to benefit from home treatment under this model.
Why it matters
Potential benefit: If successful, the model could allow appropriate patients to complete IV antibiotic courses at home safely, reducing hospital stays and improving comfort and convenience.
How similar studies have performed: Outpatient parenteral antibiotic therapy and hospital‑at‑home programs have demonstrated safety and shorter hospital stays in many settings, but combining municipal–hospital workflows with welfare technology and telemedicine in this specific model is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * Main or bi-diagnosis during stay: A692 Borreliosis G00 - G009 Central nervous system inflammatory disorders I33 Endocarditis J86 Empyema D46.3 Spondylodiscitis M86 Osteomyelitis T84 Prosthesis / osteosynthesis infections M00.0-M00.9 Pyogen / septic arthritis J40-J47 Chronic diseases of the lower respiratory tract * Competent to give consent * The infection can not be treated with oral antibiotics in monotherapy * Selected IV antibiotics must be suitable for administration via selected pumps * The patient's condition is stable and does not require frequent observation by health care professionals * The patient is motivated and willing to participate in intravenous treatment in home hospitals * Must, after training, demonstrate mastery of practical procedures related to pump handling and any other procedures described in the patient's treatment plan * The home must be suitable for intravenous antibiotic treatment; access to refrigerators, hygienic conditions, social conditions * The patient must have a mobile phone and be able to handle the system for fast and secure communication with the Regional Response Center (RRO) Exclusion criteria: * consent not given
Where this trial is running
Kristiansund
- Helse Møre og Romsdal HF, Kristiansund sjukehus, Medisinsk Avdeling — Kristiansund, Norway (Recruiting)
Study contacts
- Study coordinator: Inger Stokke, MSc
- Email: inger.stokke@helse-mr.no
- Phone: +47 41928023
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.